Table 2.
Summary of univariate and multivariate analyses results for biochemical-failure free rate.
| Parameters | Univariate |
Multivariate |
||
|---|---|---|---|---|
| Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
| Age | 1.002 (0.965–1.040) | 0.9227 | ||
| PSA (<20 vs. ≥20) | 3.082 (1.912–4.967) | <0.0001 | 2.929 (1.799–4.770) | <0.0001 |
| T stage (T1c–T2c vs. T3a–T4) | 1.513 (0.867–2.638) | 0.1449 | 1.301 (0.793–2.137) | 0.2976 |
| Gleason score (≤7 vs. ≥8) | 1.569 (0.966–2.549) | 0.0689 | ||
| ADT (Yes vs. No) | 1.051 (0.656–1.684) | 0.8360 | ||
CI: confidence interval, PSA: prostate specific antigen, ADT: androgen-deprivation therapy.